ProQR Therapeutics
PRQR
PRQR
47 hedge funds and large institutions have $37.2M invested in ProQR Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 46 → 47 (+1)
0.26% less ownership
Funds ownership: 23.16% → 22.9% (-0.26%)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
47
Holding in Top 10
2
Calls
$156K
Puts
$44K
Top Buyers
| 1 | +$763K | |
| 2 | +$154K | |
| 3 | +$69K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$66.3K |
| 5 |
Millennium Management
New York
|
+$57.5K |
Top Sellers
| 1 | -$288K | |
| 2 | -$246K | |
| 3 | -$229K | |
| 4 |
Two Sigma Investments
New York
|
-$161K |
| 5 |
Two Sigma Advisers
New York
|
-$118K |